184 related articles for article (PubMed ID: 28570499)
21. [Citalopram].
Taéron C
Rev Infirm; 2008 Nov; (145):47-9. PubMed ID: 19044198
[No Abstract] [Full Text] [Related]
22. A new role for nortriptyline in depression associated with vascular disease?
Kunte H; Rentzsch J; Kronenberg G
Am J Psychiatry; 2015 Feb; 172(2):201. PubMed ID: 25640936
[No Abstract] [Full Text] [Related]
23. Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment.
Poulet E; Brunelin J; Boeuve C; Lerond J; D'Amato T; Dalery J; Saoud M
Eur Psychiatry; 2004 Sep; 19(6):382-3. PubMed ID: 15363481
[TBL] [Abstract][Full Text] [Related]
24. Radio electric treatment vs. Es-Citalopram in the treatment of panic disorders associated with major depression: an open-label, naturalistic study.
Mannu P; Rinaldi S; Fontani V; Castagna A; Margotti ML
Acupunct Electrother Res; 2009; 34(3-4):135-49. PubMed ID: 20344882
[TBL] [Abstract][Full Text] [Related]
25. Case report of a 24-year-old man with resolution of treatment-resistant major depressive disorder and comorbid PTSD using rTMS.
Nakama H; Garcia A; O'Brien K; Ellis N
J ECT; 2014 Mar; 30(1):e9-10. PubMed ID: 24553322
[TBL] [Abstract][Full Text] [Related]
26. Maintaining remission of depression with repetitive transcranial magnetic stimulation during pregnancy: a case report.
Burton C; Gill S; Clarke P; Galletly C
Arch Womens Ment Health; 2014 Jun; 17(3):247-50. PubMed ID: 24638141
[TBL] [Abstract][Full Text] [Related]
27. Transcranial magnetic stimulation for medication-resistant depression.
Yip AG; Carpenter LL
J Clin Psychiatry; 2010 Apr; 71(4):502-3. PubMed ID: 20409447
[No Abstract] [Full Text] [Related]
28. A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium.
Demyttenaere K; Hemels ME; Hudry J; Annemans L
Clin Ther; 2005 Jan; 27(1):111-24. PubMed ID: 15763612
[TBL] [Abstract][Full Text] [Related]
29. Psychopharmacology of smoking cessation in patients with mental illness.
Selby P
J Psychiatry Neurosci; 2006 Sep; 31(5):360. PubMed ID: 16951737
[No Abstract] [Full Text] [Related]
30. QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.
Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Höschl C
Clin EEG Neurosci; 2015 Apr; 46(2):73-80. PubMed ID: 24711613
[TBL] [Abstract][Full Text] [Related]
31. The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression.
Linka T; Müller BW; Bender S; Sartory G
Neurosci Lett; 2004 Sep; 367(3):375-8. PubMed ID: 15337269
[TBL] [Abstract][Full Text] [Related]
32. Response to Kunte et al.
Uher R
Am J Psychiatry; 2015 Feb; 172(2):201. PubMed ID: 25640935
[No Abstract] [Full Text] [Related]
33. Citalopram-associated spontaneous ejaculations.
Virit O; Savas HA
J Clin Psychopharmacol; 2008 Jun; 28(3):360-1. PubMed ID: 18480704
[No Abstract] [Full Text] [Related]
34. A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury.
Rapoport MJ; Mitchell RA; McCullagh S; Herrmann N; Chan F; Kiss A; Feinstein A; Lanctôt KL
J Clin Psychiatry; 2010 Sep; 71(9):1125-30. PubMed ID: 20441723
[TBL] [Abstract][Full Text] [Related]
35. Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.
Berlim MT; Van den Eynde F; Tovar-Perdomo S; Chachamovich E; Zangen A; Turecki G
World J Biol Psychiatry; 2014 Sep; 15(7):570-8. PubMed ID: 25050453
[TBL] [Abstract][Full Text] [Related]
36. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
37. Transcranial magnetic stimulation as an antidepressant alternative in a patient with Brugada syndrome and recurrent syncope.
Alampay MM; Haigney MC; Flanagan MC; Perito RM; Love KM; Grammer GG
Mayo Clin Proc; 2014 Nov; 89(11):1584-7. PubMed ID: 25444490
[TBL] [Abstract][Full Text] [Related]
38. Depersonalization/derealization disorder after exposure to mefloquine.
McEvoy K; Anton B; Chisolm MS
Psychosomatics; 2015; 56(1):98-102. PubMed ID: 25619678
[No Abstract] [Full Text] [Related]
39. Quality of Life and Functioning in Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder After Treatment With Citalopram Monotherapy.
Steiner AJ; Boulos N; Mirocha J; Wright SM; Collison KL; IsHak WW
Clin Neuropharmacol; 2017; 40(1):16-23. PubMed ID: 27764051
[TBL] [Abstract][Full Text] [Related]
40. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
